Serum Folic Acid Levels in Preterm Infants (FALIPI)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Mehmet Yekta, Zekai Tahir Burak Maternity and Teaching Hospital
ClinicalTrials.gov Identifier:
NCT01360528
First received: May 23, 2011
Last updated: February 15, 2012
Last verified: February 2011
  Purpose

Therefore preterm infants must need folic acid replacement than term babies.


Condition
Very Low Birth Weight Baby

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Zekai Tahir Burak Maternity and Teaching Hospital

Resource links provided by NLM:


Further study details as provided by Zekai Tahir Burak Women's Health Research and Education Hospital:

Enrollment: 100
Study Start Date: February 2011
Study Completion Date: October 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Extremely low birth weight
Extremely low birth weight under 1000 gram
Very low birth weight
Between 1000-1500 gram babies
Low birth weight
Between 1500-2500 gram

Detailed Description:

All babies need to different vitamin supplementation. Especially preterm infants need some vitamin supplements. Folic acid is very important structure of part of cell growing.ın theorically; preterm infants have very rapid cell reproduction capacity than term infants. Therefore preterm infants must need folic acid replacement than term babies. The investigators want to determine preterm infants folic acid levels due to gestational age whether needs folic acid replacement.

  Eligibility

Ages Eligible for Study:   24 Weeks to 34 Weeks
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Extremely low birth weight, Very low birth weight, Low birth weight

Criteria

Inclusion Criteria:

-All preterm infants

Exclusion Criteria:

-Major congenital anomaly

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01360528

Locations
Turkey
Zekai Tahir Burak Maternity Teaching Hospital, Neonatology Unit
Ankara, Turkey, 06600
Sponsors and Collaborators
Mehmet Yekta
  More Information

No publications provided

Responsible Party: Mehmet Yekta, Zekai Tahir Burak Maternity and Teaching Hospital
ClinicalTrials.gov Identifier: NCT01360528     History of Changes
Other Study ID Numbers: ztb5326315185
Study First Received: May 23, 2011
Last Updated: February 15, 2012
Health Authority: Turkey: Ministry of Health

Keywords provided by Zekai Tahir Burak Women's Health Research and Education Hospital:
Folic acid replacement
Folic acid
Preterm neonate

Additional relevant MeSH terms:
Birth Weight
Body Weight
Signs and Symptoms
Folic Acid
Vitamin B Complex
Vitamins
Micronutrients
Growth Substances
Physiological Effects of Drugs
Pharmacologic Actions
Hematinics
Hematologic Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on July 28, 2014